Philip Morris recruits FDA vet as part of its move away from cigarettesnews2022-05-05T12:57:53+00:00May 5th, 2022|Fierce Pharma|
AZ’s Farxiga nabs heart failure win in bid to catch up to Lilly, Boehringer’s Jardiancenews2022-05-05T12:50:21+00:00May 5th, 2022|Fierce Pharma|
Thermo Fisher, Charles River join robotics outfit Multiply Labs’ quest to automate cell therapy productionnews2022-05-05T11:45:23+00:00May 5th, 2022|Fierce Pharma|
Move over, Roche: AstraZeneca and Daiichi’s Enhertu snags FDA nod for earlier breast cancer usenews2022-05-05T09:57:10+00:00May 5th, 2022|Fierce Pharma|
FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms returnnews2022-05-04T19:29:02+00:00May 4th, 2022|Fierce Pharma|
Prostate Cancer: Janssen’s Commitment to Patients Begins with Sciencenews2022-05-04T17:47:09+00:00May 4th, 2022|Fierce Pharma|
Takeda spinout Phathom clinches FDA twin nods for GI infection combos—plus timely capital infusionnews2022-05-04T15:21:11+00:00May 4th, 2022|Fierce Pharma|
Amarin, after 33% revenue decline, aims to ‘stabilize’ US sales and grow in Europenews2022-05-04T15:16:33+00:00May 4th, 2022|Fierce Pharma|
Regeneron counts on Eylea’s track record to fend off Roche rival Vabysmonews2022-05-04T15:07:43+00:00May 4th, 2022|Fierce Pharma|
Moderna tunes booster pitch ahead of potential shift to private COVID vaccine market this fallnews2022-05-04T14:10:55+00:00May 4th, 2022|Fierce Pharma|
